Moderna filed for FDA approval of its mRNA-1083 combination shot last year. The submission put the biotech on track to win ...

Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the Company has voluntarily withdrawn the pending Biologics License Application (BLA ...

After discussions with the FDA, Moderna has withdrawn its application for a combination shot, which had demonstrated efficacy in eliciting antibodies in data announced earlier this month.

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

A day after the FDA tightened the restrictions for winning vaccine approvals, Moderna Inc. is pulling its application for ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) ...

Today vaccine maker Moderna announced it voluntarily pulled its licensing submission for the combination seasonal ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

Zevtera, an advanced-generation cephalosporin, is available for treating Staphylococcus aurues bacteremia and two other other ...

Since bird flu was first discovered in U.S. cattle last year, the virus has spread to more than 1,000 herds across the ...